Results
1
-
1
of
1
Phase II trial of combination therapy of gemcitabine plus anti-angiogenic vaccination of elpamotide in patients with advanced or recurrent biliary tract cancer
,
Investigational New Drugs
[DOI: 10.1007/s10637-014-0197-z]